Tech Tackles Cancer Boston Aims to Crush Pediatric Cancer

November 7th Charity Concert Sold Out; Simulcast Set Up for Fans to Cheer On Favorite Singers from Home

BOSTON–(BUSINESS WIRE)–#AIHack/Reduce, a Boston-based non-profit organization focused on creating talent and technology for the global big data-driven economy, today announced that the annual Tech Tackles Cancer (TTC) Boston charity event, being held this year on November 7, 2023 at the Sinclair in Cambridge, MA from 6-10 pm ET, is officially sold out.


“It has been an amazing response; we’re on track to raise over $250K this year! The Boston technology community has really come together this year to support the fight against pediatric cancer, and I want to offer my sincerest thanks to everyone,” said Chris Lynch, founder of TTC and CEO of AtScale. “We’re planning a hell of a show, and we’re thrilled there will be a full house in attendance to have a great time and keep the donations coming.”

Due to the overwhelming response to this year’s event, TTC has set up a livestream of the performance so those at home can still watch the concert, donate to support their favorites, and vote for the best performers of the night. The livestream can be accessed here on the day of the show: https://evt.live/tech-tackles-cancer-boston-2023.

Veteran Boston on-air personality Adam12 will be serving as the event’s emcee. The event will also have a silent auction this year as well, where guests can continue to raise money for St. Baldrick’s and One Mission through in-person donations.

Since 2012, TTC has harnessed the power of the Boston technology community to raise awareness and funds to support pediatric cancer causes. Past events have raised more than $3M in donations for organizations focused on pediatric cancer treatment and research.

This year’s event will feature technology executives performing a single song backed by Boston-based Tony Savarino and the Savtones. Awards will be given for best vocals, best stage presence and most funds raised, and the audience will be able to vote for their favorite performances.

TTC would also like to remind anyone planning on attending that the dress code is “rock show chic.”

The lineup of featured performers for TTC Boston 2023 include the below; Click the links to support your favorite performer and make a donation to benefit pediatric cancer research and family/patient services:

Dino Cattaneo, Founder, AL4EP

Bob Elliott, VP, Storage Sales, Mainline Information Systems

Emily Iarocci, Director, Customer Success Management, Veracode

Chris Lynch, founder of TTC and CEO, AtScale

Austin Martin, SVP Strategy and Operations, Snyk

Lily McIntyre, Digital Content Specialist, Wasabi

Patrick Osborne, SVP and GM of Cloud and Data Infrastructure Platforms, HPE

Michal Peleg, Head of People, Tyk

John Procaccini, Director Of Business Operations, TEKsystems

Chris Selland, Partner, TechCXO

Mark Shirman, CEO, BizAnalytica

Dave Signori, VP of Network Services, Product Management, Infoblox

Matt Smith, Principal, Delin Design

Kate Strachnyi, Founder and Community Manager, Datacated

Corporate sponsors for TTC Boston 2023 include:

Alice Cooper’s Solid Rock Teen Centers

AtScale

Delin Design

Escalate PR

Guyer Group

High Tech Ventures

HPE

Infinidat

Infoblox

LoginVSI

Mimecast

Pure Storage

RapDev

ScienceLogic

SCS Financial

Snowplow

Snyk

Starburst

Striim

TechCXO

TEKsystems

ThreatX

Tintri

Toric

Tyk

Valence

Veracode

Wasabi

Wells Fargo Advisors

Please visit techtacklesx.org for more information on sponsorships and donations.

About Tech Tackles Cancer

Tech Tackles Cancer is a program run by Hack/Reduce, a non-profit organization focused on creating talent and technology for the global big data-driven economy. TTC brings together tech companies that want to give back and support life-saving pediatric cancer research and outreach programs. For more information, go to techtacklesx.org.

Contacts

Jeff Drew

Guyer Group for Tech Tackles Cancer

+1.617.233.5109

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.